At exit, Creganna Medical (Creganna) was a global manufacturing leader of delivery devices for the minimally invasive vascular surgery market. See how it was significantly transformed from a medical component manufacturer to a global leader in end-to-end manufacturing …
Creganna Medical
Together we achieved
- Strengthening of Creganna’s position as a leading manufacturer in minimally invasive surgery delivery devices
- Positioning Creganna as a leader in the higher growth segments of the market such as structural heart and electrophysiology
- Expanding its global manufacturing footprint with 6 sites across the USA, Latin America, Asia and Europe
- Sale to a trade buyer
This was accomplished by
- Completing two transformative acquisitions, Precision Wire Components and ABT, that deepened Creganna’s manufacturing capabilities, widened its product portfolio, expanded its geographic footprint and improved its cost position
- Recruiting top-tier managers and board members from leading medical device OEMs
- Making significant strategic investments to build a global manufacturing footprint with 6 sites across the USA, Latin America, Asia and Europe – combining high value added capabilities and low cost agility
- Developing design capabilities, enabling Creganna to deliver an end-to-end solution to its clients and be completely embedded with them from prototyping to volume manufacturing
The metrics
2010
Acquisition year
2016
Exit year
$895m
Exit value
Trade sale
Exit type
6
Manufacturing sites
Revenue growth
2010 - $131m
2015 - $249m